CKPT · Categories · Form 4
CKPT - SEC Form 4 insider transactions
Checkpoint Therapeutics Inc. (CKPT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for CKPT
- Large owner Fortress Biotech, Inc. sold $129,000 worth of shares (100,000 units at $1.29) and returned $25,101,221 worth of shares to the company (6,122,249 units at $4.10), closing all direct ownership in the company (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Director Weiss Michael S was granted 62,195 shares, increasing direct ownership by 36% to 187,007 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Director Salzman Barry M was granted 12,195 shares, closing all direct ownership in the company (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Director Rosenwald Lindsay A Md was granted 62,195 shares, closing all direct ownership in the company (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- CEO, President and Director Oliviero James F Iii closing all direct ownership in the company (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Director Herskowitz Neil was granted 12,195 shares, closing all direct ownership in the company (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Chief Financial Officer Gray William Garrett closing all direct ownership in the company (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Director Bechon Christian was granted 12,195 shares, closing all direct ownership in the company (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Director Amit Sharma was granted 12,195 shares, closing all direct ownership in the company (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- CEO, President and Director Oliviero James F Iii sold $60,964 worth of shares (15,090 units at $4.04), decreasing direct ownership by 0.40% to 3,759,929 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Chief Financial Officer Gray William Garrett sold $49,904 worth of shares (12,322 units at $4.05), decreasing direct ownership by 0.84% to 1,446,322 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Large owner Fortress Biotech, Inc. was granted 18,500 shares, increasing direct ownership by 0.30% to 6,222,249 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- CEO, President and Director Oliviero James F Iii sold $64,027 worth of shares (19,564 units at $3.27), decreasing direct ownership by 0.52% to 3,775,019 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Chief Financial Officer Gray William Garrett sold $271,984 worth of shares (74,110 units at $3.67), decreasing direct ownership by 5% to 1,458,644 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Chief Financial Officer Gray William Garrett was granted 500,000 shares, increasing direct ownership by 48% to 1,532,754 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- CEO, President and Director Oliviero James F Iii was granted 1,500,000 shares, increasing direct ownership by 65% to 3,794,583 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Large owner Fortress Biotech, Inc. was granted 2,468,215 shares, increasing direct ownership by 66% to 6,203,749 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- CEO, President and Director Oliviero James F Iii gifted 900,000 shares and sold $3,074,764 worth of shares (822,397 units at $3.74), decreasing direct ownership by 43% to 2,294,583 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Chief Financial Officer Gray William Garrett sold $1,076,412 worth of shares (268,432 units at $4.01), decreasing direct ownership by 21% to 1,032,754 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Director Weiss Michael S was granted 12,638 shares (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Director Salzman Barry M was granted 17,638 shares, increasing direct ownership by 15% to 134,812 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Director Rosenwald Lindsay A Md was granted 12,638 shares, increasing direct ownership by 10% to 144,812 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- CEO, President and Director Oliviero James F Iii was granted 2,077,700 shares, increasing direct ownership by 107% to 4,016,980 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Chief Financial Officer Gray William Garrett was granted 629,000 shares, increasing direct ownership by 94% to 1,301,186 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Director Bechon Christian was granted 14,994 shares, increasing direct ownership by 13% to 129,523 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Director Herskowitz Neil was granted 17,638 shares, increasing direct ownership by 15% to 134,812 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Large owner Fortress Biotech, Inc. was granted 146,341 shares, increasing direct ownership by 4% to 3,735,534 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- CEO, President and Director Oliviero James F Iii sold $50,450 worth of shares (24,610 units at $2.05) and gifted 37,890 shares, decreasing direct ownership by 3% to 1,939,280 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Chief Financial Officer Gray William Garrett sold $26,858 worth of shares (13,038 units at $2.06), decreasing direct ownership by 2% to 672,186 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Gray William Garrett was granted 540,000 shares, increasing direct ownership by 372% to 685,224 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Oliviero James F Iii was granted 1,660,000 shares, increasing direct ownership by 486% to 2,001,780 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Weiss Michael S was granted 82,051 shares (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Amit Sharma was granted 32,051 shares, increasing direct ownership by 64% to 82,051 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Salzman Barry M was granted 82,051 shares, increasing direct ownership by 234% to 117,174 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Rosenwald Lindsay A Md was granted 82,051 shares, increasing direct ownership by 164% to 132,174 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Herskowitz Neil was granted 82,051 shares, increasing direct ownership by 234% to 117,174 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Bechon Christian was granted 82,051 shares, increasing direct ownership by 253% to 114,529 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Fortress Biotech, Inc. was granted 193,905 shares, increasing direct ownership by 10% to 2,096,278 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Oliviero James F Iii sold $12,142 worth of shares (5,894 units at $2.06) and gifted 9,056 shares, decreasing direct ownership by 4% to 341,780 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Gray William Garrett sold $4,212 worth of shares (2,035 units at $2.07), decreasing direct ownership by 1% to 145,224 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Gray William Garrett sold $8,024 worth of shares (4,115 units at $1.95), decreasing direct ownership by 3% to 147,259 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Oliviero James F Iii sold $23,919 worth of shares (11,900 units at $2.01) and gifted 12,950 shares, decreasing direct ownership by 7% to 356,730 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Fortress Biotech, Inc. was granted 158,134 shares, increasing direct ownership by 9% to 1,902,373 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- Fortress Biotech, Inc. was granted 80,906 shares, increasing direct ownership by 5% to 1,744,239 units (SEC Form 4)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4 filed by Fortress Biotech, Inc.4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4 filed by Weiss Michael S4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4 filed by Rosenwald Lindsay A Md4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4 filed by Salzman Barry M4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4 filed by Herskowitz Neil4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4 filed by Bechon Christian4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4 filed by Boilen Scott4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4 filed by Oliviero James F Iii4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4 filed by Gray William Garrett4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4 filed by Fortress Biotech, Inc.4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4: Gray William Garrett sold $15,108 worth of shares (3,154 units at $4.79), decreasing direct ownership by 6% to 49,379 units (for withholding tax)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4: Oliviero James F Iii sold $48,945 worth of shares (10,261 units at $4.77), decreasing direct ownership by 5% to 182,121 units (withholding tax)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4: Gray William Garrett sold $12,540 worth of shares (1,858 units at $6.75), decreasing direct ownership by 3% to 52,533 units (for withholding tax)4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4: Oliviero James F Iii sold $25,761 worth of shares (3,817 units at $6.75), decreasing direct ownership by 2% to 192,382 units to satisfy tax liability4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4: Fortress Biotech, Inc. was granted 368,907 shares, increasing direct ownership by 33% to 1,503,713 units4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)
- SEC Form 4: Oliviero James F Iii sold $301,140 worth of shares (276,000 units at $1.09), decreasing direct ownership by 10% to 2,562,003 units4 - Checkpoint Therapeutics, Inc. (0001651407) (Issuer)